These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21268733)

  • 1. Home monitoring of warfarin effects.
    Lippi G; Franchini M
    N Engl J Med; 2011 Jan; 364(4):378; author reply 378-9. PubMed ID: 21268733
    [No Abstract]   [Full Text] [Related]  

  • 2. Home monitoring of warfarin effects.
    Arellano-Rodrigo E
    N Engl J Med; 2011 Jan; 364(4):378; author reply 378-9. PubMed ID: 21268734
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial gives nod to home warfarin monitoring.
    Harv Heart Lett; 2009 Feb; 19(6):6. PubMed ID: 19579310
    [No Abstract]   [Full Text] [Related]  

  • 5. Rethinking warfarin for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Sep; 55(1426):77. PubMed ID: 24081386
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of home testing of international normalized ratio on clinical events.
    Matchar DB; Jacobson A; Dolor R; Edson R; Uyeda L; Phibbs CS; Vertrees JE; Shih MC; Holodniy M; Lavori P;
    N Engl J Med; 2010 Oct; 363(17):1608-20. PubMed ID: 20961244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. At-Home Versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS).
    Phibbs CS; Love SR; Jacobson AK; Edson R; Su P; Uyeda L; Matchar DB;
    J Gen Intern Med; 2016 Sep; 31(9):1061-7. PubMed ID: 27234663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a new method of warfarin management on patient satisfaction, time, and cost.
    Meyer S; Frei CR; Daniels KR; Forcade NA; Bussey M; Bussey-Smith KL; Bussey HI
    Pharmacotherapy; 2013 Nov; 33(11):1147-55. PubMed ID: 24038425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shortchang'ed. Dollars don't add for prothrombin home monitoring,
    Southwick K
    CAP Today; 2002 Aug; 16(8):44, 48-50, 52-8. PubMed ID: 12242871
    [No Abstract]   [Full Text] [Related]  

  • 10. Warfarin: better the devil you know.
    Blockman M
    Cardiovasc J Afr; 2017; 28(6):344-345. PubMed ID: 29297543
    [No Abstract]   [Full Text] [Related]  

  • 11. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
    [No Abstract]   [Full Text] [Related]  

  • 12. More Medicare patients eligible for home warfarin monitoring.
    Thompson CA
    Am J Health Syst Pharm; 2008 May; 65(9):800, 802. PubMed ID: 18436725
    [No Abstract]   [Full Text] [Related]  

  • 13. The economic costs of routine INR monitoring in infants and children--examining point-of-care devices used within the home setting compared to traditional anticoagulation clinic monitoring.
    Gaw JR; Crowley S; Monagle P; Jones S; Newall F
    Thromb Res; 2013 Jul; 132(1):26-31. PubMed ID: 23746471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Nunan D; Heneghan C
    Heart; 2015 Nov; 101(21):1689-90. PubMed ID: 26135804
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient education series. Coumadin (warfarin) therapy.
    Holcomb SS
    Nursing; 2006 Nov; 36(11):45-6. PubMed ID: 17079920
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
    Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
    Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
    Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCOs following innovative CMS remote monitoring initiative: self-testing service is designed to lower costs and improve outcomes for anticoagulation therapy.
    Albrecht R
    Manag Care Q; 2006; 14(1):13-6. PubMed ID: 17590971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.